A citation-based method for searching scientific literature

Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow, Filip Krag Knop, Sten Madsbad, Henrik Ullits Andersen. Lancet Diabetes Endocrinol 2016
Times Cited: 67



Nitesh D Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini, Min Yang, Ajay Chaudhuri, Paresh Dandona. Diabetes Care 2016
Times Cited: 43




List of shared articles



Times cited


Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial.
Thomas F Dejgaard, Signe Schmidt, Christian S Frandsen, Dorte Vistisen, Sten Madsbad, Henrik U Andersen, Kirsten Nørgaard. Diabetes Obes Metab 2020
5

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode. Diabetes Care 2016
95

Effect of the GLP-1 receptor agonist exenatide on impaired awareness of hypoglycemia in type 1 diabetes; a randomized controlled trial.
Lian A van Meijel, Hanne M Rooijackers, Cees J Tack, Bastiaan E de Galan. J Clin Endocrinol Metab 2019
4

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.
Alfonso Galderisi, Jennifer Sherr, Michelle VanName, Lori Carria, Melinda Zgorski, Eileen Tichy, Kate Weyman, Eda Cengiz, Stuart Weinzimer, William Tamborlane. J Clin Endocrinol Metab 2018
9

Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes.
Sara E Lingow, Sandra D Burke, Amie D Brooks, Pat S Rafferty. Diabetes Spectr 2019
0

Incretin-based therapies for patients with type 1 diabetes: a meta-analysis.
Lili Liu, Zhuo Shao, Ying Xia, Jiabi Qin, Yang Xiao, Zhiguang Zhou, Zubing Mei. Endocr Connect 2019
6

Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis.
Patoulias Dimitrios, Doumas Michael, Kotsis Vasilios, Stavropoulos Konstantinos, Imprialos Konstantinos, Zografou Ioanna, Petidis Konstantinos, Bakatselos Spyridon, Karagiannis Asterios. Curr Diabetes Rev 2020
11



Treatment strategies for hypertension in patients with type 1 diabetes.
Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Alexandros Sachinidis, Michalis Doumas, Vasilios G Athyros. Expert Opin Pharmacother 2020
1

New Frontiers in the Treatment of Type 1 Diabetes.
Jeremy T Warshauer, Jeffrey A Bluestone, Mark S Anderson. Cell Metab 2020
21

Adjunct Antihyperglycemic Agents in Overweight and Obese Adults With Type 1 Diabetes.
Diana Isaacs, Stephanie Yager, Marcie Parker, Lauren Wolfe, Jennifer Luxenburg, Sanela Lekic. Ann Pharmacother 2019
3

Adjunctive therapy for glucose control in patients with type 1 diabetes.
Kira Harris, Cassie Boland, Lisa Meade, Dawn Battise. Diabetes Metab Syndr Obes 2018
8

A systematic review and dose-response meta-analysis on the efficacy of dapagliflozin in patients with type 1 diabetes mellitus.
Ahmed Abu-Zaid, Abdulaziz Khalaf Altowairqi, Thusharika Dissanayaka, Artem Oganesyan, Akshaya Srikanth Bhagavathul, Habeeb Alhabeeb, Amirah Baradhwan, Sara Alomar, Sebastian Tom. Pharmacol Res 2021
0

Double Diabetes: A Growing Problem Requiring Solutions.
Djordje S Popovic, Nikolaos Papanas. Exp Clin Endocrinol Diabetes 2021
0


Efficacy and safety of incretin-based drugs in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
Wen Wang, Yun Gao, Dawei Chen, Chun Wang, Xiaobing Feng, Xingwu Ran. Diabetes Res Clin Pract 2017
6


Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Julia K Mader, Lene Jensen, Steen H Ingwersen, Erik Christiansen, Simon Heller, Thomas R Pieber. Clin Pharmacokinet 2016
6


Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.
Nitesh D Kuhadiya, Ben Prohaska, Husam Ghanim, Paresh Dandona. Diabetes Obes Metab 2019
1


Adjunct therapies in treatment of type 1 diabetes.
Itivrita Goyal, Alamgir Sattar, Megan Johnson, Paresh Dandona. J Diabetes 2020
2

Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
Justinne Guyton, Michelle Jeon, Amie Brooks. Am J Health Syst Pharm 2019
0


The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta-analysis.
Saniya Tandon, Salma Ayis, David Hopkins, Seeromanie Harding, Marietta Stadler. Diabetes Obes Metab 2021
1

Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes.
Mustafa Tosur, Maria J Redondo, Sarah K Lyons. Curr Diab Rep 2018
4

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016
68